Everest Organics

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE334C01029
  • NSEID:
  • BSEID: 524790
INR
271.45
9.9 (3.79%)
BSENSE

Jun 18

BSE+NSE Vol: 2.08 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
BDH Industries
Ambalal Sarabhai
Gennex Lab.
Aarey Drugs
Everest Organics
Zenotech Lab.
Nectar Lifesci.
Lyka Labs
Kerala Ayurveda
Astonea Labs
Sat Kartar Life
Why is Everest Organics Ltd ?
1
Weak Long Term Fundamental Strength with a -7.30% CAGR growth in Operating Profits over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 14.03 times
  • The company has been able to generate a Return on Equity (avg) of 2.02% signifying low profitability per unit of shareholders funds
2
Flat results in Mar 26
  • PAT(Latest six months) At Rs 2.99 cr has Grown at -26.17%
  • OPERATING PROFIT TO INTEREST (Q) Lowest at 2.43 times
  • DEBTORS TURNOVER RATIO(HY) Lowest at 1.63 times
3
Stock is technically in a Mildly Bearish range
  • A key technical factor - Bollinger Band has been Bearish since 25 May 2026
4
Underperformed the market in the last 1 year
  • Even though the market (BSE500) has generated returns of 0.84% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -21.72% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Everest Organics for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Everest Organics
-21.72%
-0.33
65.09%
Sensex
-4.95%
-0.37
13.26%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
1.56%
EBIT Growth (5y)
-7.30%
EBIT to Interest (avg)
0.60
Debt to EBITDA (avg)
14.38
Net Debt to Equity (avg)
0.65
Sales to Capital Employed (avg)
1.82
Tax Ratio
31.09%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
2.12%
ROE (avg)
2.02%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
46
Industry P/E
34
Price to Book Value
3.38
EV to EBIT
22.87
EV to EBITDA
15.38
EV to Capital Employed
2.44
EV to Sales
1.55
PEG Ratio
0.09
Dividend Yield
NA
ROCE (Latest)
10.68%
ROE (Latest)
7.37%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

11What is working for the Company
PAT(Q)

At Rs 2.63 cr has Grown at 80.1% (vs previous 4Q average

ROCE(HY)

Highest at 9.86%

PBT LESS OI(Q)

At Rs 2.01 cr has Grown at 45.9% (vs previous 4Q average

DEBT-EQUITY RATIO(HY)

Lowest at 0.68 times

PBDIT(Q)

Highest at Rs 6.70 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 13.74%

-13What is not working for the Company
PAT(Latest six months)

At Rs 2.99 cr has Grown at -26.17%

OPERATING PROFIT TO INTEREST (Q)

Lowest at 2.43 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 1.63 times

INTEREST(Q)

Highest at Rs 2.76 cr

Loading Valuation Snapshot...
Here's what is working for Everest Organics
Profit After Tax (PAT) - Quarterly
At Rs 2.63 cr has Grown at 80.1% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 1.46 Cr
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 2.01 cr has Grown at 45.9% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 1.38 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 6.70 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 13.74%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Debt-Equity Ratio - Half Yearly
Lowest at 0.68 times
in the last five half yearly periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Everest Organics
Interest - Quarterly
At Rs 2.76 cr has Grown at 124.39%
Quarter on Quarter (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Operating Profit to Interest - Quarterly
Lowest at 2.43 times
in the last five quarters
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Interest - Quarterly
Highest at Rs 2.76 cr
in the last five quarters and Increased by 124.39 % (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Debtors Turnover Ratio- Half Yearly
Lowest at 1.63 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio